Influenzinum

Product NDC
0220-5182
11-digit product format
002205182
Labeler code
0220
Product ID
0220-5182_5bae95dc-4e7b-4674-e063-6394a90ae690
Type
HUMAN OTC DRUG
Nonproprietary name
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Dosage form
PELLET
Route
ORAL
Labeler
Boiron
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2026-09-14
Substance
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Active strength
9; 9; 9 [hp_C]/9[hp_C]; [hp_C]/9[hp_C]; [hp_C]/9[hp_C]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Influenzinum
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)9 [hp_C]/9[hp_C]
INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)9 [hp_C]/9[hp_C]
INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)9 [hp_C]/9[hp_C]

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0220-5182-31002205182319 [hp_C] in 1 TUBE (0220-5182-31) 2026-09-14NoNoCurrent
0220-5182-41002205182419 [hp_C] in 1 TUBE (0220-5182-41) 2026-09-14NoNoCurrent